News
Fintel on MSN13h
HC Wainwright & Co. Downgrades UroGen Pharma (URGN)Fintel reports that on May 22, 2025, HC Wainwright & Co. downgraded their outlook for UroGen Pharma (NasdaqGM:URGN) from Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback